Abstract: The invention provides modified virus Ankara (MVA), a replication-deficient strain of vaccinia virus, expressing human immunodeficiency virus (HIV) env, gag, and pol genes.
Type:
Application
Filed:
December 10, 2014
Publication date:
August 27, 2015
Applicants:
EMORY UNIVERSITY, NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES (NIAID), UNITED STATES DEPARTMENT OF HEAL
Inventors:
BERNARD MOSS, LINDA WYATT, PATRICIA EARL, HARRIET L. ROBINSON
Abstract: The invention provides modified virus Ankara (MVA), a replication-deficient strain of vaccinia virus, expressing human immunodeficiency virus (HIV) env, gag, and pol genes.
Type:
Grant
Filed:
January 10, 2011
Date of Patent:
December 23, 2014
Assignees:
Emory University, National Institute of Allergy and Infectious Diseases (NIAID), The United States of America, as represented by the Department of Health and Human Services
Inventors:
Bernard Moss, Linda Wyatt, Patricia Earl, Harriet L. Robinson